| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $267.27M | - | |
| Dir | 390.7K | $88.26M | - | |
| CEO | 152.2K | $34.38M | - | |
| VP | 72.6K | $16.41M | - | |
| CFO | 59.6K | $13.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2021 | Cozadd Bruce C59 | Chairman &CEO | Sell | 7,950 | $162.01 | $1,287,979.50 | -2.4% | |
| Dec 4, 2020 | Carr Patricia65 | VP, Finance &Pao | Sell | 62 | $152.55 | $9,457.97 | -1.0% | |
| Dec 3, 2020 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,250 | $142.46 | $178,080.00 | -0.2% | |
| Nov 12, 2020 | Enright Patrick G74 | Director | Sell | 9,929 | $146.72 | $1,456,738.14 | -12.5% | |
| Nov 6, 2020 | Larkin Finbar61 | SVP, Technical Operations | Sell | 197 | $151.93 | $29,930.21 | -1.4% | |
| Nov 5, 2020 | O'Keefe Kenneth W63 | Director | Sell | 11,000 | $154.86 | $1,703,420.66 | -10.4% | |
| Nov 4, 2020 | Sohn Catherine A.55 | Director | Sale+OE | 12,500 | $153.44 | $1,918,000.00 | -37.0% | |
| Nov 4, 2020 | Berns Paul L | Director | Sale+OE | 4,691 | $150.42 | $705,603.66 | -11.2% | |
| Nov 3, 2020 | Cozadd Bruce C59 | Chairman &CEO | Sell | 3,500 | $151.47 | $530,130.00 | -0.5% | |
| Oct 1, 2020 | Cozadd Bruce C59 | Chairman &CEO | Sell | 4,500 | $141.94 | $638,730.00 | -1.3% |